TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
RDNT

RadNet Inc

Healthcare · Diagnostics & Research

70.70$ -1.6% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow RDNT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
8.5% 8.3% 10.4% 15.3% 12.0% 9.0% 21.8% 11.4% 10.2% 13.7% 12.7% 14.6%
8.3% 7.5% 7.5% 7.2% 7.5% 12.8% 14.4% 13.0% 12.9% 11.7% 10.8% 7.5%
0.3% 0.9% 0.7% 0.7% 0.8% 0.8% 1.2% 1.9% 1.7% 1.7% 1.6% 2.7%
0.4% 0.4% 0.3% 7.2% 1.6% 0.4% 3.2% 3.3% -0.4% – – –
-8.0% -5.6% -3.2% 2.3% 1.9% -6.7% 5.1% -7.0% -4.1% -2.5% -3.1% -0.5%
7.1% 16.5% 7.4% 9.6% 14.9% 8.8% 11.7% 16.8% 17.4% 10.9% 10.3% 10.5%
-7.5% -12.0% -7.4% -8.5% -15.0% -8.6% -11.8% -16.8% -17.3% -12.5% -12.7% -16.9%
0.0% 0.1% 0.1% 0.2% 0.1% – 0.1% 0.5% – – – –
-1.7% -1.7% 53.9% -0.2% -0.2% -0.3% -0.2% -0.1% 0.0% – – –
-0.1% -0.1% 0.0% -4.2% -1.2% 1.9% -4.0% 7.2% 6.6% -2.7% 9.0% 3.5%
-2.1% 3.7% -0.7% -3.5% -1.1% 2.2% -4.3% 8.0% 6.5% 12.1% 21.7% 3.5%
-1.1% 0.0% 2.3% 3.3% -4.2% 2.6% 5.8% 2.5% -0.5% 13.3% 21.7% 1.3%
1.4% -8.2% 2.9% 5.7% -2.9% 0.3% 10.1% -5.4% -7.2% 2.7% 2.5% 4.2%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?